日本小児循環器学会雑誌 Pediatric Cardiology and Cardiac Surgery

In recent years, fetal ultrasound screening has become widespread, leading to most congenital diseases being diagnosed prenatally. Nonetheless, some cases still progress to fetal heart failure leading to fetal death during their uterine period, while others with congenital heart disease (CHD) still experience severe deterioration, making survival difficult even with intensive postnatal therapy. Various prenatal interventions for these diseases have been implemented mainly in Europe and the United States, and there are many reports concerning their outcomes and effects on prognostic improvement. In Japan, clinical studies and trials on fetal interventions for severe CHD (e.g., treatments for fetal arrhythmias and severe aortic valve stenosis) have continued to be conducted and steadily implemented. Conversely, there have yet been no reports in Japan on the administration of nonsteroidal anti-inflammatory drugs for Ebstein disease with circular shunt, which can advance in the near future. There are ethical issues surrounding maternal and fetal health and the medical insurance system that need to be addressed through multidisciplinary collaboration. Nonetheless, we expect our fetal cardiac interventions and therapies to be able to match international standards.